iORGANBIO and Mitsui Chemicals Pair AI With Oxygen-Permeable Plates to Solve Organoid Reproducibility as FDA Ends Animal Testing
AI-generated summary iORGANBIO has received a strategic investment from Mitsui Chemicals through the 321Catalyst fund and is collaborating to combine its closed-loop artificial intelligence platform with high-oxygen-permeability cell culture plates. iORGANBIO states that its CellForge platform belongs to a category of technology called Physical AI, combining artificial intelligence prediction with robotic execution in a continuous feedback loop.